Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bimal N. Desai is active.

Publication


Featured researches published by Bimal N. Desai.


Science | 2008

Deletion of Trpm7 Disrupts Embryonic Development and Thymopoiesis Without Altering Mg2+ Homeostasis

Jie Jin; Bimal N. Desai; Betsy Navarro; Adriana Donovan; Nancy C. Andrews; David E. Clapham

The gene transient receptor potential-melastatin-like 7 (Trpm7) encodes a protein that functions as an ion channel and a kinase. TRPM7 has been proposed to be required for cellular Mg2+ homeostasis in vertebrates. Deletion of mouse Trpm7 revealed that it is essential for embryonic development. Tissue-specific deletion of Trpm7 in the T cell lineage disrupted thymopoiesis, which led to a developmental block of thymocytes at the double-negative stage and a progressive depletion of thymic medullary cells. However, deletion of Trpm7 in T cells did not affect acute uptake of Mg2+ or the maintenance of total cellular Mg2+. Trpm7-deficient thymocytes exhibited dysregulated synthesis of many growth factors that are necessary for the differentiation and maintenance of thymic epithelial cells. The thymic medullary cells lost signal transducer and activator of transcription 3 activity, which accounts for their depletion when Trpm7 is disrupted in thymocytes.


Proceedings of the National Academy of Sciences of the United States of America | 2002

FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction

Bimal N. Desai; Benjamin R. Myers; Stuart L. Schreiber

FKBP12-rapamycin associated protein (FRAP, also known as mTOR or RAFT) is the founding member of the phosphatidylinositol kinase-related kinase family and functions as a sensor of physiological signals that regulate cell growth. Signals integrated by FRAP include nutrients, cAMP levels, and osmotic stress, and cellular processes affected by FRAP include transcription, translation, and autophagy. The mechanisms underlying the integration of such diverse signals by FRAP are largely unknown. Recently, FRAP has been reported to be regulated by mitochondrial dysfunction and depletion of ATP levels. Here we show that exposure of cells to hyperosmotic conditions (and to glucose-deficient growth medium) results in rapid and reversible dissipation of the mitochondrial proton gradient. These results suggest that the ability of FRAP to mediate osmotic stress response (and glucose deprivation response) is by means of an intermediate mitochondrial dysfunction. We also show that in addition to cytosolic FRAP a large portion of FRAP associates with the mitochondrial outer membrane. The results support the existence of a stress-sensing module consisting of mitochondria and mitochondrial outer membrane-associated FRAP. This module allows the cell to integrate a variety of stress signals that affect mitochondrial function and regulate a growth checkpoint involving p70 S6 kinase.


Developmental Cell | 2012

Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis

Bimal N. Desai; Grigory Krapivinsky; Betsy Navarro; Luba Krapivinsky; Brett C. Carter; Sebastien Febvay; Markus Delling; Anirudh Penumaka; I. Scott Ramsey; Yunona Manasian; David E. Clapham

Transient receptor potential melastatin-like 7 (TRPM7) is a channel protein that also contains a regulatory serine-threonine kinase domain. Here, we find that Trpm7-/- T cells are deficient in Fas-receptor-induced apoptosis and that TRPM7 channel activity participates in the apoptotic process and is regulated by caspase-dependent cleavage. This function of TRPM7 is dependent on its function as a channel, but not as a kinase. TRPM7 is cleaved by caspases at D1510, disassociating the carboxy-terminal kinase domain from the pore without disrupting the phosphotransferase activity of the released kinase but substantially increasing TRPM7 ion channel activity. Furthermore, we show that TRPM7 regulates endocytic compartmentalization of the Fas receptor after receptor stimulation, an important process for apoptotic signaling through Fas receptors. These findings raise the possibility that other members of the TRP channel superfamily are also regulated by caspase-mediated cleavage, with wide-ranging implications for cell death and differentiation.


Pflügers Archiv: European Journal of Physiology | 2005

TRP channels and mice deficient in TRP channels

Bimal N. Desai; David E. Clapham

Transient receptor potential (TRP) channels are a superfamily of functionally versatile cation-permeant ion channels present in almost all mammalian cell types. Although they were initially proposed as store-operated calcium channels, recent progress shows that they exhibit a variety of regulatory and functional themes. Here, we summarize the most salient features of TRP channels, the approaches that are providing meaningful discoveries, and the challenges ahead. We primarily emphasize the understanding gleaned from mouse models engineered to be deficient in various members of TRP superfamily and from the human patients that suffer clinically due to defects in TRP channels.


Cell Reports | 2014

Caspase-11 Controls Interleukin-1β Release through Degradation of TRPC1

Bénédicte F. Py; Mingzhi Jin; Bimal N. Desai; Anirudh Penumaka; Hong Zhu; Maike Kober; Alexander Dietrich; Marta M. Lipinski; Thomas Henry; David E. Clapham; Junying Yuan

SUMMARY Caspase-11 is a highly inducible caspase that controls both inflammatory responses and cell death. Caspase-11 controls interleukin 1β (IL-1β) secretion by potentiating caspase-1 activation and induces caspase-1-independent pyroptosis downstream of noncanonical NLRP3 inflammasome activators such as lipopolysaccharide (LPS) and Gram-negative bacteria. However, we still know very little about the downstream mechanism of caspase-11 in regulating inflammation because the known substrates of caspase-11 are only other caspases. Here, we identify the cationic channel subunit transient receptor potential channel 1 (TRPC1) as a substrate of caspase-11. TRPC1 deficiency increases the secretion of IL-1β without modulating caspase-1 cleavage or cell death in cultured macrophages. Consistently, trpc1−/− mice show higher IL-1β secretion in the sepsis model of intraperitoneal LPS injection. Altogether, our data suggest that caspase-11 modulates the cationic channel composition of the cell and thus regulates the unconventional secretion pathway in a manner independent of caspase-1.


Frontiers in Immunology | 2014

Purinergic and Calcium Signaling in Macrophage Function and Plasticity

Bimal N. Desai; Norbert Leitinger

In addition to a fundamental role in cellular bioenergetics, the purine nucleotide adenosine triphosphate (ATP) plays a crucial role in the extracellular space as a signaling molecule. ATP and its metabolites serve as ligands for a family of receptors that are collectively referred to as purinergic receptors. These receptors were first described and characterized in the nervous system but it soon became evident that they are expressed ubiquitously. In the immune system, purinergic signals regulate the migration and activation of immune cells and they may also orchestrate the resolution of inflammation (1, 2). The intracellular signal transduction initiated by purinergic receptors is strongly coupled to Ca2+-signaling, and co-ordination of these pathways plays a critical role in innate immunity. In this review, we provide an overview of purinergic and Ca2+-signaling in the context of macrophage phenotypic polarization and discuss the implications on macrophage function in physiological and pathological conditions.


Immunity | 2018

Chanzyme TRPM7 Mediates the Ca2+ Influx Essential for Lipopolysaccharide-Induced Toll-Like Receptor 4 Endocytosis and Macrophage Activation

Michael S. Schappe; Kalina Szteyn; Marta Stremska; Suresh K. Mendu; Taylor K. Downs; Philip V. Seegren; Michelle A. Mahoney; Sumeet Dixit; Julia Krupa; Eric J. Stipes; Jason S. Rogers; Samantha E. Adamson; Norbert Leitinger; Bimal N. Desai

Summary Toll‐like receptors (TLRs) sense pathogen‐associated molecular patterns to activate the production of inflammatory mediators. TLR4 recognizes lipopolysaccharide (LPS) and drives the secretion of inflammatory cytokines, often contributing to sepsis. We report that transient receptor potential melastatin‐like 7 (TRPM7), a non‐selective but Ca2+‐conducting ion channel, mediates the cytosolic Ca2+ elevations essential for LPS‐induced macrophage activation. LPS triggered TRPM7‐dependent Ca2+ elevations essential for TLR4 endocytosis and the subsequent activation of the transcription factor IRF3. In a parallel pathway, the Ca2+ signaling initiated by TRPM7 was also essential for the nuclear translocation of NF&kgr;B. Consequently, TRPM7‐deficient macrophages exhibited major deficits in the LPS‐induced transcriptional programs in that they failed to produce IL‐1&bgr; and other key pro‐inflammatory cytokines. In accord with these defects, mice with myeloid‐specific deletion of Trpm7 are protected from LPS‐induced peritonitis. Our study highlights the importance of Ca2+ signaling in macrophage activation and identifies the ion channel TRPM7 as a central component of TLR4 signaling. Graphical Abstract Figure. No Caption available. HighlightsTRPM7 is essential for LPS‐induced macrophage activationTRPM7 mediates the Ca2+ influx necessary for TLR4 endocytosisLPS‐induced phosphorylation and translocation of NF&kgr;B p65 and IRF3 depend on TRPM7Mice with a myeloid‐specific Trpm7 deletion are resistant to LPS‐induced peritonitis &NA; Schappe et al. show that genetic deletion of Trpm7 in macrophages or pharmacological inhibition of TRPM7 channel prevents macrophage activation due to the loss of TRPM7‐mediated Ca2+ influx in response to LPS. The study identifies TRPM7 as a Ca2+‐entry pathway required for macrophage activation.


Scientific Reports | 2017

Hematopoietic pannexin 1 function is critical for neuropathic pain

Janelle L. Weaver; Sanja Arandjelovic; Gregory G. Brown; Suresh K. Mendu; Michael S. Schappe; Monica W. Buckley; Yu-Hsin Chiu; Shaofang Shu; Jin K. Kim; Joyce Chung; Julia Krupa; Vesna Jevtovic-Todorovic; Bimal N. Desai; Kodi S. Ravichandran; Douglas A. Bayliss

Neuropathic pain symptoms respond poorly to available therapeutics, with most treated patients reporting unrelieved pain and significant impairment in daily life. Here, we show that Pannexin 1 (Panx1) in hematopoietic cells is required for pain-like responses following nerve injury in mice, and a potential therapeutic target. Panx1 knockout mice (Panx1−/−) were protected from hypersensitivity in two sciatic nerve injury models. Bone marrow transplantation studies show that expression of functional Panx1 in hematopoietic cells is necessary for mechanical hypersensitivity following nerve injury. Reconstitution of irradiated Panx1 knockout mice with hematopoietic Panx1−/− cells engineered to re-express Panx1 was sufficient to recover hypersensitivity after nerve injury; this rescue required expression of a Panx1 variant that can be activated by G protein-coupled receptors (GPCRs). Finally, chemically distinct Panx1 inhibitors blocked development of nerve injury-induced hypersensitivity and partially relieved this hypersensitivity after it was established. These studies indicate that Panx1 expressed in immune cells is critical for pain-like effects following nerve injury in mice, perhaps via a GPCR-mediated activation mechanism, and suggest that inhibition of Panx1 may be useful in treating neuropathic pain.


The Journal of General Physiology | 2018

Revisiting multimodal activation and channel properties of Pannexin 1

Yu-Hsin Chiu; Michael S. Schappe; Bimal N. Desai; Douglas A. Bayliss

Chiu and colleagues review the primary evidence for divergent activation mechanisms and unitary properties of Pannexin 1 channels.


Circulation Research | 2017

Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone

Miranda E. Good; Yu-Hsin Chiu; Ivan K. H. Poon; Christopher B. Medina; Joshua T. Butcher; Suresh K. Mendu; Leon J. DeLalio; Alexander W. Lohman; Norbert Leitinger; Eugene J. Barrett; Ulrike Lorenz; Bimal N. Desai; Iris Z. Jaffe; Douglas A. Bayliss; Brant E. Isakson; Kodi S. Ravichandran

Rationale: Resistant hypertension is a major health concern with unknown cause. Spironolactone is an effective antihypertensive drug, especially for patients with resistant hypertension, and is considered by the World Health Organization as an essential medication. Although spironolactone can act at the mineralocorticoid receptor (MR; NR3C2), there is increasing evidence of MR-independent effects of spironolactone. Objective: Here, we detail the unexpected discovery that Panx1 (pannexin 1) channels could be a relevant in vivo target of spironolactone. Methods and Results: First, we identified spironolactone as a potent inhibitor of Panx1 in an unbiased small molecule screen, which was confirmed by electrophysiological analysis. Next, spironolactone inhibited &agr;-adrenergic vasoconstriction in arterioles from mice and hypertensive humans, an effect dependent on smooth muscle Panx1, but independent of the MR NR3C2. Last, spironolactone acutely lowered blood pressure, which was dependent on smooth muscle cell expression of Panx1 and independent of NR3C2. This effect, however, was restricted to steroidal MR antagonists as a nonsteroidal MR antagonist failed to reduced blood pressure. Conclusions: These data suggest new therapeutic modalities for resistant hypertension based on Panx1 inhibition.

Collaboration


Dive into the Bimal N. Desai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David E. Clapham

Howard Hughes Medical Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Julia Krupa

University of Virginia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge